CF
CERE

Corebridge Financial’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Corebridge Financial’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,372
Closed -$56.1K – 3066
2024
Q2 		$56.1K Buy
+1,372
New +$57.1K ﹤0.01% 2867

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Corebridge Financial's CERE Position: Q3 2024 in Review

Corebridge Financial sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 1,372 shares — an estimated $56.1K sold.

Corebridge Financial first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $56.1K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Corebridge Financial reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Corebridge Financial sold 1,372 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $56.1K.
  • Corebridge Financial first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Corebridge Financial's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $56.1K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Corebridge Financial's 13F filing for Q3 2024, filed 13 Nov 2024.